Health care stocks were rising late Monday afternoon, with the NYSE Health Care Index adding 0.4% and the Health Care Select Sector SPDR Fund (XLV) up 0.1%.
The iShares Biotechnology ETF (IBB) was shedding 0.1%.
In corporate news, Lipella Pharmaceuticals (LIPO) shares soared 110.1% after the company said Monday that it started the enrollment of the first people for its phase 2a trial assessing LP-310 for oral lichen planus.
vTv Therapeutics (VTVT) shares sank 23% after it said Friday that the US Food and Drug Administration has placed a clinical hold on its cadisegliatin program for type 1 diabetes.
Philips (PHG) shares jumped 13.2% after the company reported higher adjusted earnings in Q2 and maintained its full-year comparable sales outlook.
Ventyx Biosciences (VTYX) shares tumbled 22.5% after the company said a phase 2 trial of its VTX958 candidate drug for people with Crohn's disease failed to meet the primary endpoint.
Comments